| HGNC Family | Basic helix-loop-helix proteins (BHLH) |
| Name | MYC associated factor X |
| Description | The protein encoded by this gene is a member of the basic helix-loop-helix leucine zipper (bHLHZ) family of transcription factors. It is able to form homodimers and heterodimers with other family members, which include Mad, Mxi1 and Myc. Myc is an oncoprotein implicated in cell proliferation, differentiation and apoptosis. The homodimers and heterodimers compete for a common DNA target site (the E box) and rearrangement among these dimer forms provides a complex system of transcriptional regulation. Mutations of this gene have been reported to be associated with hereditary pheochromocytoma. A pseudogene of this gene is located on the long arm of chromosome 7. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2012] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nMAX is a ubiquitously expressed basic/helix‐loop‐helix leucine zipper (bHLH‐LZ) protein that serves as an obligate dimerization partner for several key transcription factors—including the oncogenic MYC and its antagonists (e.g., MAD and MNT)—thereby governing the specificity and affinity of E‐box DNA binding. Structural and biophysical studies have revealed that MAX–containing complexes not only stabilize heterodimer formation but also act as sensitive molecular “readers” of local epigenetic modifications, as MAX displays differential binding to DNA substrates bearing distinct cytosine modifications. In addition, post‐translational events such as phosphorylation further modulate the assembly and activity of these transcriptional complexes, ultimately influencing cell proliferation and differentiation."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "7"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn various human tumors, alterations in MAX—including germline and somatic mutations, inactivation, or altered expression—disrupt its normal role in transcriptional regulation and are closely associated with oncogenesis. Defective MAX function has been implicated in a range of neoplasms such as pheochromocytomas, paragangliomas, gastrointestinal stromal tumors, small cell lung cancers, B‐cell lymphomas, neuroblastomas, and other neuroendocrine tumors. In these contexts, loss or mutation of MAX not only perturbs the balance of MYC–MAX–MAD transcriptional networks but also deregulates cell cycle checkpoints and tumor suppressor pathways, thereby contributing to malignant progression and poor clinical outcomes."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "8", "end_ref": "21"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its classical role in MYC‐mediated transcription, MAX is itself a dynamic node within broader regulatory networks. Its expression and function are finely tuned by multiple mechanisms—including alternative splicing events that generate isoforms such as ΔMax, regulation by microRNAs, and interactions with additional transcription factors like C/EBPα and MITF. Such modulation enables MAX to integrate diverse signals from environmental stress, growth factor pathways (e.g. PI3K/AKT), and even circadian regulators, thereby influencing differentiation, immune regulation, and even aspects of cellular metabolism. Moreover, innovative therapeutic strategies are now exploring approaches to disrupt aberrant MYC–MAX interactions or harness MAX’s intrinsic cell‐penetrating capacity to reprogram transcription in disease states."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "22", "end_ref": "40"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Satish K Nair, Stephen K Burley "}, {"type": "b", "children": [{"type": "t", "text": "X-ray structures of Myc-Max and Mad-Max recognizing DNA. Molecular bases of regulation by proto-oncogenic transcription factors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/s0092-8674(02)01284-9"}], "href": "https://doi.org/10.1016/s0092-8674(02"}, {"type": "t", "text": "01284-9) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12553908"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12553908"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Anamika Banerjee, Jianzhong Hu, Dixie J Goss "}, {"type": "b", "children": [{"type": "t", "text": "Thermodynamics of protein-protein interactions of cMyc, Max, and Mad: effect of polyions on protein dimerization."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochemistry (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1021/bi0522551"}], "href": "https://doi.org/10.1021/bi0522551"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16475822"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16475822"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Joakim Crona, Rajani Maharjan, Alberto Delgado Verdugo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MAX mutations status in Swedish patients with pheochromocytoma and paraganglioma tumours."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Fam Cancer (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10689-013-9666-3"}], "href": "https://doi.org/10.1007/s10689-013-9666-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23743562"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23743562"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Steven Fletcher, Edward V Prochownik "}, {"type": "b", "children": [{"type": "t", "text": "Small-molecule inhibitors of the Myc oncoprotein."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochim Biophys Acta (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbagrm.2014.03.005"}], "href": "https://doi.org/10.1016/j.bbagrm.2014.03.005"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24657798"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24657798"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Daniel Diolaiti, Lisa McFerrin, Patrick A Carroll, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Functional interactions among members of the MAX and MLX transcriptional network during oncogenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochim Biophys Acta (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbagrm.2014.05.016"}], "href": "https://doi.org/10.1016/j.bbagrm.2014.05.016"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24857747"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24857747"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Michael Allevato, Eugene Bolotin, Mark Grossman, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sequence-specific DNA binding by MYC/MAX to low-affinity non-E-box motifs."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0180147"}], "href": "https://doi.org/10.1371/journal.pone.0180147"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28719624"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28719624"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Pavel Macek, Matthew J Cliff, Kevin J Embrey, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Myc phosphorylation in its basic helix-loop-helix region destabilizes transient α-helical structures, disrupting Max and DNA binding."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.RA118.002709"}], "href": "https://doi.org/10.1074/jbc.RA118.002709"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29695509"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29695509"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Dimitrios Iliopoulos, Asaf Rotem, Kevin Struhl "}, {"type": "b", "children": [{"type": "t", "text": "Inhibition of miR-193a expression by Max and RXRα activates K-Ras and PLAU to mediate distinct aspects of cellular transformation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-11-0425"}], "href": "https://doi.org/10.1158/0008-5472.CAN-11-0425"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21670079"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21670079"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Iñaki Comino-Méndez, Francisco J Gracia-Aznárez, Francesca Schiavi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Genet (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ng.861"}], "href": "https://doi.org/10.1038/ng.861"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21685915"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21685915"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Nelly Burnichon, Alberto Cascón, Francesca Schiavi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-12-0160"}], "href": "https://doi.org/10.1158/1078-0432.CCR-12-0160"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22452945"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22452945"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Octavio A Romero, Manuel Torres-Diz, Eva Pros, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MAX inactivation in small cell lung cancer disrupts MYC-SWI/SNF programs and is synthetic lethal with BRG1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Discov (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/2159-8290.CD-13-0799"}], "href": "https://doi.org/10.1158/2159-8290.CD-13-0799"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24362264"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24362264"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Nan Qin, Aguirre A de Cubas, Ruben Garcia-Martin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Opposing effects of HIF1α and HIF2α on chromaffin cell phenotypic features and tumor cell proliferation: Insights from MYC-associated factor X."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Cancer (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ijc.28868"}], "href": "https://doi.org/10.1002/ijc.28868"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24676840"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24676840"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Esther Korpershoek, Djamailys Koffy, Bert H Eussen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Complex MAX Rearrangement in a Family With Malignant Pheochromocytoma, Renal Oncocytoma, and Erythrocytosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Endocrinol Metab (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/jc.2015-2592"}], "href": "https://doi.org/10.1210/jc.2015-2592"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26670126"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26670126"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Dongxue Wang, Hideharu Hashimoto, Xing Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MAX is an epigenetic sensor of 5-carboxylcytosine and is altered in multiple myeloma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nucleic Acids Res (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/nar/gkw1184"}], "href": "https://doi.org/10.1093/nar/gkw1184"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27903915"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27903915"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Inga-Marie Schaefer, Yuexiang Wang, Cher-Wei Liang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MAX inactivation is an early event in GIST development that regulates p16 and cell proliferation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncomms14674"}], "href": "https://doi.org/10.1038/ncomms14674"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28270683"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28270683"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Giuseppe Sicoli, Hervé Vezin, Karin Ledolter, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Conformational tuning of a DNA-bound transcription factor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nucleic Acids Res (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/nar/gkz291"}], "href": "https://doi.org/10.1093/nar/gkz291"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31020309"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31020309"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Haritha Mathsyaraja, Brian Freie, Pei-Feng Cheng, et al. "}, {"type": "b", "children": [{"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "Max"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " deletion destabilizes MYC protein and abrogates Eµ-"}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "Myc"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " lymphomagenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genes Dev (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1101/gad.325878.119"}], "href": "https://doi.org/10.1101/gad.325878.119"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31395740"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31395740"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Sandrine Petignot, Adrian F Daly, Emilie Castermans, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Pancreatic Neuroendocrine Neoplasm Associated with a Familial MAX Deletion."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Horm Metab Res (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1055/a-1186-0790"}], "href": "https://doi.org/10.1055/a-1186-0790"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32521546"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32521546"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Takahisa Yamashita, Morihiro Higashi, Shuji Momose, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Decreased MYC-associated factor X (MAX) expression is a new potential biomarker for adverse prognosis in anaplastic large cell lymphoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-020-67500-w"}], "href": "https://doi.org/10.1038/s41598-020-67500-w"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32587329"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32587329"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Amanda J Seabrook, Jessica E Harris, Sofia B Velosa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Multiple Endocrine Tumors Associated with Germline MAX Mutations: Multiple Endocrine Neoplasia Type 5?"}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Endocrinol Metab (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/clinem/dgaa957"}], "href": "https://doi.org/10.1210/clinem/dgaa957"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33367756"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33367756"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Weixu Ma, Mingzhu Cao, Shilei Bi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MAX deficiency impairs human endometrial decidualization through down-regulating OSR2 in women with recurrent spontaneous abortion."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Tissue Res (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00441-022-03579-z"}], "href": "https://doi.org/10.1007/s00441-022-03579-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35146559"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35146559"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Iyad Sultan, Can E Senkal, Suriyan Ponnusamy, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of the sphingosine-recycling pathway for ceramide generation by oxidative stress, and its role in controlling c-Myc/Max function."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem J (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BJ20051083"}], "href": "https://doi.org/10.1042/BJ20051083"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16201965"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16201965"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Yi Ting, Daniel J Medina, Roger K Strair, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Differentiation-associated miR-22 represses Max expression and inhibits cell cycle progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2010.03.030"}], "href": "https://doi.org/10.1016/j.bbrc.2010.03.030"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20214878"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20214878"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Marie-Eve Beaulieu, François-Olivier McDuff, Vincent Frappier, et al. "}, {"type": "b", "children": [{"type": "t", "text": "New structural determinants for c-Myc specific heterodimerization with Max and development of a novel homodimeric c-Myc b-HLH-LZ."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Mol Recognit (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jmr.2203"}], "href": "https://doi.org/10.1002/jmr.2203"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22733550"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22733550"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Ivan Babic, Erik S Anderson, Kazuhiro Tanaka, et al. "}, {"type": "b", "children": [{"type": "t", "text": "EGFR mutation-induced alternative splicing of Max contributes to growth of glycolytic tumors in brain cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Metab (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cmet.2013.04.013"}], "href": "https://doi.org/10.1016/j.cmet.2013.04.013"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23707073"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23707073"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Jason M Link, Peter J Hurlin "}, {"type": "b", "children": [{"type": "t", "text": "The activities of MYC, MNT and the MAX-interactome in lymphocyte proliferation and oncogenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochim Biophys Acta (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbagrm.2014.04.004"}], "href": "https://doi.org/10.1016/j.bbagrm.2014.04.004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24731854"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24731854"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Katrin Kemmerer, Julia E Weigand "}, {"type": "b", "children": [{"type": "t", "text": "Hypoxia reduces MAX expression in endothelial cells by unproductive splicing."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS Lett (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.febslet.2014.11.011"}], "href": "https://doi.org/10.1016/j.febslet.2014.11.011"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25451222"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25451222"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Jutta Wanner, Darlene Romashko, Douglas S Werner, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Reversible linkage of two distinct small molecule inhibitors of Myc generates a dimeric inhibitor with improved potency that is active in myc over-expressing cancer cell lines."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0121793"}], "href": "https://doi.org/10.1371/journal.pone.0121793"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25875098"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25875098"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Iñaki Comino-Méndez, Luis J Leandro-García, Guillermo Montoya, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Functional and in silico assessment of MAX variants of unknown significance."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Mol Med (Berl) (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00109-015-1306-y"}], "href": "https://doi.org/10.1007/s00109-015-1306-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26070438"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26070438"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Huabo Wang, Peter Teriete, Angela Hu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Direct inhibition of c-Myc-Max heterodimers by celastrol and celastrol-inspired triterpenoids."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.6116"}], "href": "https://doi.org/10.18632/oncotarget.6116"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26474287"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26474287"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Martin G Belinsky, Lori Rink, Kathy Q Cai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Somatic loss of function mutations in neurofibromin 1 and MYC associated factor X genes identified by exome-wide sequencing in a wild-type GIST case."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Cancer (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12885-015-1872-y"}], "href": "https://doi.org/10.1186/s12885-015-1872-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26555092"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26555092"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "L S Resende, C E Amaral, R B S Soares, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Social stress in adolescents induces depression and brain-region-specific modulation of the transcription factor MAX."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Transl Psychiatry (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/tp.2016.202"}], "href": "https://doi.org/10.1038/tp.2016.202"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27727240"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27727240"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Mikaël Bédard, Loïka Maltais, Martin Montagne, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Miz-1 and Max compete to engage c-Myc: implication for the mechanism of inhibition of c-Myc transcriptional activity by Miz-1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proteins (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/prot.25214"}], "href": "https://doi.org/10.1002/prot.25214"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27859590"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27859590"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Loïka Maltais, Martin Montagne, Mikaël Bédard, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Biophysical characterization of the b-HLH-LZ of ΔMax, an alternatively spliced isoform of Max found in tumor cells: Towards the validation of a tumor suppressor role for the Max homodimers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0174413"}], "href": "https://doi.org/10.1371/journal.pone.0174413"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28350847"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28350847"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Birke Bausch, Francesca Schiavi, Ying Ni, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed Prevention."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "JAMA Oncol (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1001/jamaoncol.2017.0223"}], "href": "https://doi.org/10.1001/jamaoncol.2017.0223"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28384794"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28384794"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Miroslav Hejna, Wooyoung M Moon, Jeffrey Cheng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Local genomic features predict the distinct and overlapping binding patterns of the bHLH-Zip family oncoproteins MITF and MYC-MAX."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pigment Cell Melanoma Res (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/pcmr.12762"}], "href": "https://doi.org/10.1111/pcmr.12762"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30548162"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30548162"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Qinbo Zhou, Bo Yu, Chastain Anderson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncEGFL7OS regulates human angiogenesis by interacting with MAX at the EGFL7/miR-126 locus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Elife (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7554/eLife.40470"}], "href": "https://doi.org/10.7554/eLife.40470"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30741632"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30741632"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Lele Liu, Xingguo Song, Xinyi Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A three-platelet mRNA set: MAX, MTURN and HLA-B as biomarker for lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cancer Res Clin Oncol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00432-019-03032-9"}], "href": "https://doi.org/10.1007/s00432-019-03032-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31552488"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31552488"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "M Carmen Lafita-Navarro, Judit Liaño-Pons, Andrea Quintanilla, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The MNT transcription factor autoregulates its expression and supports proliferation in MYC-associated factor X (MAX)-deficient cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.RA119.010389"}], "href": "https://doi.org/10.1074/jbc.RA119.010389"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31919096"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31919096"}]}, {"type": "r", "ref": 40, "children": [{"type": "t", "text": "Olga Blaževitš, Nityanand Bolshette, Donatella Vecchio, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MYC-Associated Factor MAX is a Regulator of the Circadian Clock."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Sci (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/ijms21072294"}], "href": "https://doi.org/10.3390/ijms21072294"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32225100"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32225100"}]}]}]}
|
| Synonyms | BHLHD4 |
| Proteins | MAX_HUMAN |
| NCBI Gene ID | 4149 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
MAX has 10,141 functional associations with biological entities spanning 9 categories (molecular profile, organism, functional term, phrase or reference, chemical, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 143 datasets.
Click the + buttons to view associations for MAX from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Achilles Cell Line Gene Essentiality Profiles | cell lines with fitness changed by MAX gene knockdown relative to other cell lines from the Achilles Cell Line Gene Essentiality Profiles dataset. | |
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of MAX gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of MAX gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of MAX gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of MAX gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of MAX gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of MAX gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| Biocarta Pathways | pathways involving MAX protein from the Biocarta Pathways dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of MAX gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of MAX gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of MAX gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of MAX gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of MAX gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of MAX gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CCLE Cell Line Gene Mutation Profiles | cell lines with MAX gene mutations from the CCLE Cell Line Gene Mutation Profiles dataset. | |
| CCLE Cell Line Proteomics | Cell lines associated with MAX protein from the CCLE Cell Line Proteomics dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with MAX gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MAX gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of MAX gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of MAX gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| ClinVar Gene-Phenotype Associations | phenotypes associated with MAX gene from the curated ClinVar Gene-Phenotype Associations dataset. | |
| ClinVar Gene-Phenotype Associations 2025 | phenotypes associated with MAX gene from the curated ClinVar Gene-Phenotype Associations 2025 dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of MAX gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| CM4AI U2OS Cell Map Protein Localization Assemblies | assemblies containing MAX protein from integrated AP-MS and IF data from the CM4AI U2OS Cell Map Protein Localization Assemblies dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of MAX gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing MAX protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing MAX protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Experimental Protein Localization Evidence Scores | cellular components containing MAX protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 | cellular components containing MAX protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with MAX protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with MAX protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| CORUM Protein Complexes | protein complexs containing MAX protein from the CORUM Protein Complexes dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of MAX gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with MAX gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with MAX gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with MAX gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| dbGAP Gene-Trait Associations | traits associated with MAX gene in GWAS and other genetic association datasets from the dbGAP Gene-Trait Associations dataset. | |
| DeepCoverMOA Drug Mechanisms of Action | small molecule perturbations with high or low expression of MAX protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores | diseases associated with MAX gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with MAX gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with MAX gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with MAX gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with MAX gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with MAX gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MAX gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MAX gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of MAX gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing MAX from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with MAX gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GAD High Level Gene-Disease Associations | diseases associated with MAX gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of MAX gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with MAX gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing MAX from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of MAX gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of MAX gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of MAX gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of MAX gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of MAX gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of MAX gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving MAX gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving MAX gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving MAX gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing MAX protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Cellular Component Annotations 2023 | cellular components containing MAX protein from the curated GO Cellular Component Annotations 2023 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing MAX protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by MAX gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by MAX gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by MAX gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of MAX gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of MAX gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of MAX gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of MAX gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of MAX gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with MAX gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of MAX gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of MAX gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of MAX gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of MAX protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of MAX gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| HPM Cell Type and Tissue Protein Expression Profiles | cell types and tissues with high or low expression of MAX protein relative to other cell types and tissues from the HPM Cell Type and Tissue Protein Expression Profiles dataset. | |
| Hub Proteins Protein-Protein Interactions | interacting hub proteins for MAX from the curated Hub Proteins Protein-Protein Interactions dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with MAX gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for MAX protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of MAX gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of MAX gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of MAX gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEA Substrates of Kinases | kinases that phosphorylate MAX protein from the curated KEA Substrates of Kinases dataset. | |
| KEGG Pathways | pathways involving MAX protein from the KEGG Pathways dataset. | |
| KEGG Pathways 2026 | pathways involving MAX protein from the KEGG Pathways 2026 dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of MAX gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of MAX gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with MAX gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of MAX gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of MAX gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of MAX gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| LOCATE Curated Protein Localization Annotations | cellular components containing MAX protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain MAX protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by MAX gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting MAX gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of MAX gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of MAX gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by MAX gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| MSigDB Cancer Gene Co-expression Modules | co-expressed genes for MAX from the MSigDB Cancer Gene Co-expression Modules dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of MAX gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of MAX gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| NURSA Protein Complexes | protein complexs containing MAX protein recovered by IP-MS from the NURSA Protein Complexes dataset. | |
| OMIM Gene-Disease Associations | phenotypes associated with MAX gene from the curated OMIM Gene-Disease Associations dataset. | |
| PANTHER Pathways | pathways involving MAX protein from the PANTHER Pathways dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for MAX from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of MAX gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of MAX gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving MAX protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving MAX protein from the Wikipathways PFOCR 2024 dataset. | |
| Phosphosite Textmining Biological Term Annotations | biological terms co-occuring with MAX protein in abstracts of publications describing phosphosites from the Phosphosite Textmining Biological Term Annotations dataset. | |
| PhosphoSitePlus Substrates of Kinases | kinases that phosphorylate MAX protein from the curated PhosphoSitePlus Substrates of Kinases dataset. | |
| PID Pathways | pathways involving MAX protein from the PID Pathways dataset. | |
| Reactome Pathways 2014 | pathways involving MAX protein from the Reactome Pathways dataset. | |
| Reactome Pathways 2024 | pathways involving MAX protein from the Reactome Pathways 2024 dataset. | |
| Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of MAX gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of MAX gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of MAX gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of MAX gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of MAX gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MAX gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of MAX gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of MAX gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of MAX gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sanger Dependency Map Cancer Cell Line Proteomics | cell lines associated with MAX protein from the Sanger Dependency Map Cancer Cell Line Proteomics dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of MAX gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Protein Ligands | ligand (protein) perturbations changing phosphorylation of MAX protein from the SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Protein Ligands dataset. | |
| Tabula Sapiens Gene-Cell Associations | cell types with high or low expression of MAX gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of MAX gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of MAX gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of MAX gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of MAX gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of MAX protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of MAX protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of MAX protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of MAX protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with MAX protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with MAX protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2014 | pathways involving MAX protein from the Wikipathways Pathways 2014 dataset. | |
| WikiPathways Pathways 2024 | pathways involving MAX protein from the WikiPathways Pathways 2024 dataset. | |